Moreover, Notch 1 expression has been related to cisplatin resistance in different types of cancers, such as head and neck squamous cell carcinoma [40] and colon carcinoma [41], and Notch 3 expression has been related to gemcitabine resistance in pancreatic cancer cells [42]. Here, NOTCH3 is linked to familial pancreatic carcinoma.